LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article: Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Patients at High Risk of Developing Gallbladder Cancer Peritoneal Metastases: Case Report and Rationale for a Prospective Clinical Trial.

    Crum, Alexander E / Sestito, Michael / Garland-Kledzik, Mary / Boone, Brian A

    Journal of clinical medicine

    2024  Volume 13, Issue 3

    Abstract: Gallbladder cancer is a devastating disease with a 5-year survival of only 18%. The majority of gallbladder cancers are discovered incidentally in patients undergoing cholecystectomy. During non-oncologic laparoscopic cholecystectomy for gallbladder ... ...

    Abstract Gallbladder cancer is a devastating disease with a 5-year survival of only 18%. The majority of gallbladder cancers are discovered incidentally in patients undergoing cholecystectomy. During non-oncologic laparoscopic cholecystectomy for gallbladder disease, gallbladder perforation occurs in 29% of cases and spillage of gallstones occurs in 9% of cases. Patients with gallbladder cancer frequently develop peritoneal recurrence, particularly after intra-operative bile spillage during cholecystectomy for incidental gallbladder cancer. The high likelihood of spillage and peritoneal seeding during cholecystectomy for incidental gallbladder cancer suggests the need for prophylactic strategies to prevent peritoneal carcinomatosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) has efficacy in gallbladder cancer patients with macroscopic peritoneal disease undergoing cytoreductive surgery and has been associated with a survival advantage in a multi-institutional retrospective case series. However, the utilization of HIPEC with a prophylactic intent against the development of peritoneal disease following resection of gallbladder cancer has not yet been prospectively studied. Here, we review the literature surrounding gallbladder cancer and HIPEC, report an institutional experience utilizing prophylactic HIPEC, and discuss a recently proposed prospective clinical trial evaluating the efficacy of prophylactic HIPEC in the prevention of gallbladder peritoneal metastasis.
    Language English
    Publishing date 2024-01-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13030768
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Commentary: The Benefit of Positron Emission Tomography/Computed Tomography in Stage I and Stage II Melanomas with High-Risk DecisionDx-Melanoma Scores.

    Garland-Kledzik, Mary

    The Journal of clinical and aesthetic dermatology

    2020  Volume 16, Issue 12 Suppl 1, Page(s) S4–S5

    Language English
    Publishing date 2020-08-26
    Publishing country United States
    Document type Editorial
    ZDB-ID 2571623-2
    ISSN 1941-2789
    ISSN 1941-2789
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: ASO Author Reflections: Establishing Novel Molecular Subtypes of Appendiceal Cancer.

    Garland-Kledzik, Mary / Khader, Adam / Marzese, Diego M

    Annals of surgical oncology

    2021  Volume 29, Issue 3, Page(s) 2126–2127

    MeSH term(s) Adenocarcinoma, Mucinous ; Appendiceal Neoplasms/genetics ; Humans ; Peritoneal Neoplasms
    Language English
    Publishing date 2021-10-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1200469-8
    ISSN 1534-4681 ; 1068-9265
    ISSN (online) 1534-4681
    ISSN 1068-9265
    DOI 10.1245/s10434-021-10977-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Current and future imaging modalities in gastric cancer.

    Tham, Elwin / Sestito, Michael / Markovich, Brian / Garland-Kledzik, Mary

    Journal of surgical oncology

    2022  Volume 125, Issue 7, Page(s) 1123–1134

    Abstract: Gastric adenocarcinoma treatment can include endoscopic mucosal resection, surgery, chemotherapy, radiation, and palliative measures depending on staging. Both invasive and noninvasive staging techniques have been used to dictate the best treatment ... ...

    Abstract Gastric adenocarcinoma treatment can include endoscopic mucosal resection, surgery, chemotherapy, radiation, and palliative measures depending on staging. Both invasive and noninvasive staging techniques have been used to dictate the best treatment pathway. Here, we review the current imaging modalities used in gastric cancer as well as novel techniques to accurately stage and screen these patients.
    MeSH term(s) Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Humans ; Neoplasm Staging ; Stomach Neoplasms/diagnostic imaging ; Stomach Neoplasms/pathology ; Stomach Neoplasms/therapy
    Language English
    Publishing date 2022-04-28
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 82063-5
    ISSN 1096-9098 ; 0022-4790
    ISSN (online) 1096-9098
    ISSN 0022-4790
    DOI 10.1002/jso.26875
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management.

    Niemann, Britney / Moise, John / Sestito, Michael / Malla, Midhun / Train, Kevin / Murken, Douglas / Mayers, Keri / Groves, Emily / Garland-Kledzik, Mary

    Journal of clinical medicine

    2024  Volume 13, Issue 6

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2024-03-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13061684
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: "The Benefit Of Positron Emission Tomography/Computed Tomography In Stage I And Stage II Melanomas With High-Risk Decisiondx-Melanoma Scores".

    Williams, Andrew / Hamilton, Owen / Likar, Carly / Thomay, Alan / Garland-Kledzik, Mary

    The American surgeon

    2022  Volume 88, Issue 7, Page(s) 1446–1451

    Abstract: Introduction: Early detection of melanoma is instrumental as the 5-year survival decreases from 93.3% to <50% when metastases are present.: Methods: 297 patients at our institution had biopsies sent for DDx-M between 2014 and 2021. Patients found to ... ...

    Abstract Introduction: Early detection of melanoma is instrumental as the 5-year survival decreases from 93.3% to <50% when metastases are present.
    Methods: 297 patients at our institution had biopsies sent for DDx-M between 2014 and 2021. Patients found to have Class 2 melanomas received additional screening with yearly
    Results: Within 3 years of follow-up, 8/66 (12.1%) patients had metastases detected by
    Discussion: 18
    Conclusion: We suggest all patients with initial stage II or above melanomas receive a DDx-M score and those with class 2 receive yearly
    MeSH term(s) Dichlorodiphenyl Dichloroethylene ; Fluorodeoxyglucose F18 ; Humans ; Male ; Melanoma/diagnostic imaging ; Melanoma/pathology ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography/methods ; Radiopharmaceuticals ; Sensitivity and Specificity ; Testicular Neoplasms/pathology
    Chemical Substances Radiopharmaceuticals ; Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Dichlorodiphenyl Dichloroethylene (4M7FS82U08)
    Language English
    Publishing date 2022-03-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 202465-2
    ISSN 1555-9823 ; 0003-1348
    ISSN (online) 1555-9823
    ISSN 0003-1348
    DOI 10.1177/00031348221081760
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Exploring the Genomic Landscape of Hepatobiliary Cancers to Establish a Novel Molecular Classification System.

    Scholer, Anthony J / Marcus, Rebecca K / Garland-Kledzik, Mary / Ghosh, Debopriya / Ensenyat-Mendez, Miquel / Germany, Joshua / Santamaria-Barria, Juan A / Khader, Adam / Orozco, Javier I J / Goldfarb, Melanie

    Cancers

    2024  Volume 16, Issue 2

    Abstract: Taxonomy of hepatobiliary cancer (HBC) categorizes tumors by location or histopathology (tissue of origin, TO). Tumors originating from different TOs can also be grouped by overlapping genomic alterations (GA) into molecular subtypes (MS). The aim of ... ...

    Abstract Taxonomy of hepatobiliary cancer (HBC) categorizes tumors by location or histopathology (tissue of origin, TO). Tumors originating from different TOs can also be grouped by overlapping genomic alterations (GA) into molecular subtypes (MS). The aim of this study was to create novel HBC MSs. Next-generation sequencing (NGS) data from the AACR-GENIE database were used to examine the genomic landscape of HBCs. Machine learning and gene enrichment analysis identified MSs and their oncogenomic pathways. Descriptive statistics were used to compare subtypes and their associations with clinical and molecular variables. Integrative analyses generated three MSs with different oncogenomic pathways independent of TO (
    Language English
    Publishing date 2024-01-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16020325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Arterio-Enteric Fistula after Irreversible Electroporation.

    Lundy, Megan / Garland-Kledzik, Mary / Shen, Perry

    The American surgeon

    2019  Volume 85, Issue 1, Page(s) e55–e57

    MeSH term(s) Ablation Techniques/adverse effects ; Adenocarcinoma/therapy ; Aged ; Electroporation ; Female ; Humans ; Intestinal Fistula/diagnosis ; Intestinal Fistula/etiology ; Intestinal Fistula/therapy ; Pancreatic Neoplasms/therapy ; Vascular Fistula/diagnosis ; Vascular Fistula/etiology ; Vascular Fistula/therapy
    Language English
    Publishing date 2019-02-13
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 202465-2
    ISSN 1555-9823 ; 0003-1348
    ISSN (online) 1555-9823
    ISSN 0003-1348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Disparities in the impact of the AJCC 8th edition staging system on differentiated thyroid cancer outcomes.

    Santamaria-Barria, Juan A / Graff-Baker, Amanda N / Chang, Shu-Ching / Khader, Adam / Scholer, Anthony J / Garland-Kledzik, Mary / Goldfarb, Melanie

    Head & neck

    2022  Volume 44, Issue 10, Page(s) 2129–2141

    Abstract: Background: The impact of AJCC8 among self-reported racial/ethnic groups on differentiated thyroid cancer (DTC) outcomes is unknown.: Methods: Multivariate-regression evaluated the association between AJCC7 to AJCC8 stage change and race/ethnicity in ...

    Abstract Background: The impact of AJCC8 among self-reported racial/ethnic groups on differentiated thyroid cancer (DTC) outcomes is unknown.
    Methods: Multivariate-regression evaluated the association between AJCC7 to AJCC8 stage change and race/ethnicity in patients with DTC in the NCDB. Cox-proportional-regression evaluated whether AJCC7 to AJCC8 stage change affects overall survival (OS) differently based on reported race/ethnicity.
    Results: After adjusting for confounders, Hispanics and Asian-Pacific-Islanders (APIs) were 27% and 12% less likely to be down-staged compared to white-non-Hispanics (WNHs) (p < 0.001); black-non-Hispanics (BNHs) had no significant down-staging difference. Down-staged patients had an increased risk of death compared to patients with unchanged staging, regardless of race/ethnicity. However, based on two-way interaction, the magnitude of this negative change on survival from down-staging was only different between WNHs (HR = 2.64) and BNHs (HR = 1.77), (p = 0.04).
    Conclusions: Outcome disparities persist among self-reported racial/ethnic groups with AJCC8. Down-staged patients across all racial/ethnic groups had decreased survival compared to those with unchanged stage, with the least impact in BNHs.
    MeSH term(s) Adenocarcinoma ; Humans ; Neoplasm Staging ; Thyroid Neoplasms/surgery
    Language English
    Publishing date 2022-06-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645165-2
    ISSN 1097-0347 ; 0148-6403 ; 1043-3074
    ISSN (online) 1097-0347
    ISSN 0148-6403 ; 1043-3074
    DOI 10.1002/hed.27122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Age-related next-generation sequencing mutational analysis in 1196 melanomas.

    Santamaria-Barria, Juan A / Matsuba, Chikako / Khader, Adam / Scholar, Anthony J / Garland-Kledzik, Mary / Fischer, Trevan D / Essner, Richard / Salomon, Matthew P / Mammen, Joshua M V / Goldfarb, Melanie

    Journal of surgical oncology

    2023  Volume 127, Issue 7, Page(s) 1187–1195

    Abstract: Background and objectives: Melanoma mutational burden is high and approximately 50% have oncogenic mutations in BRAF. We sought to evaluate age-related mutational differences in melanoma.: Methods: We analyzed melanoma samples in the Genomics ... ...

    Abstract Background and objectives: Melanoma mutational burden is high and approximately 50% have oncogenic mutations in BRAF. We sought to evaluate age-related mutational differences in melanoma.
    Methods: We analyzed melanoma samples in the Genomics Evidence Neoplasia Information Exchange database. Targetable mutations were identified using the Precision Oncology Knowledge Base (OncoKB).
    Results: We found 1194 patients with a common set of 30 genes. The top mutated genes in patients <40 years old (y/o) (n = 98) were BRAF (59%), TP53 (31%), NRAS (17%), and PTEN (14%); in 40-59 y/o (n = 354) were BRAF (51%), NRAS (30%), TP53 (26%), and APC (13%); and in ≥60 y/o (n = 742) were BRAF (38%), NRAS (33%), TP53 (26%), and KDR (19%). BRAF mutations were almost mutually exclusive from NRAS mutations in <40 y/o (58/59). Mutational burden increased with age, with means of 2.39, 2.92, and 3.67 mutations per sample in patients <40, 40-59, and ≥60 y/o, respectively (p < 0.0001). There were 10 targetable mutations meeting OncoKB criteria for melanoma: BRAF (level 1), RET (level 1), KIT (level 2), NRAS (level 3A), TP53 (level 3A), and FGFR2, MET, PTEN, PIK3CA, and KRAS (level 4).
    Conclusions: Mutations in melanoma have age-related differences and demonstrates potential targetable mutations for personalized therapies.
    MeSH term(s) Humans ; Adult ; Proto-Oncogene Proteins B-raf/genetics ; Precision Medicine ; Melanoma/genetics ; Mutation ; High-Throughput Nucleotide Sequencing ; DNA Mutational Analysis ; Skin Neoplasms/genetics
    Chemical Substances Proto-Oncogene Proteins B-raf (EC 2.7.11.1)
    Language English
    Publishing date 2023-03-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 82063-5
    ISSN 1096-9098 ; 0022-4790
    ISSN (online) 1096-9098
    ISSN 0022-4790
    DOI 10.1002/jso.27239
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top